Zhejiang Starry Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
The page contains a free Sustainability report covering Zhejiang Starry Pharmaceutical Co Ltd. Full ESG assessment of Zhejiang Starry Pharmaceutical Co Ltd are reached by signing up for free. This assessment of Zhejiang Starry Pharmaceutical Co Ltd uses intelligence from across the web and also from available disclosures by Zhejiang Starry Pharmaceutical Co Ltd.
Zhejiang Starry Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Zhejiang Starry Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Zhejiang Starry Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Zhejiang Starry Pharmaceutical Co Ltd report the average age of the workforce?
Does Zhejiang Starry Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Zhejiang Starry Pharmaceutical Co Ltd offer flexible work?
Does Zhejiang Starry Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Zhejiang Starry Pharmaceutical Co Ltd conduct supply chain audits?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Zhejiang Starry Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose water use targets?
Does Zhejiang Starry Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Zhejiang Starry Pharmaceutical Co Ltd have a product recall in the last two years?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Zhejiang Starry Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Zhejiang Starry Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose parental leave metrics?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Zhejiang Starry Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Zhejiang Starry Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Zhejiang Starry Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose its waste policy?
Does Zhejiang Starry Pharmaceutical Co Ltd report according to TCFD requirements?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose energy use targets?
Does Zhejiang Starry Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Zhejiang Starry Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Zhejiang Starry Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.